Search - tctmd.com

Displaying 81 - 100 of 138

Sort: Relevancy | Date

Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond

Presentation TVT 2013

Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond

Presenter: David Cohen

June 13, 2013

TAVR Cost-effectiveness and Reimbursement: A Global Gordian Knot

Presentation TVT 2013

TAVR Cost-effectiveness and Reimbursement: A Global Gordian Knot

Presenter: David Cohen

June 12, 2013

News Daily News

新型抗凝血剂在心房纤维颤动病患治疗中比华法林抗凝血剂更具性价比(2)

May 13, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

May 13, 2013

Can We Afford TAVR? Economic Insights from the PARTNER Trial

Presentation TCTAP 2013

Can We Afford TAVR? Economic Insights from the PARTNER Trial

Presenter: David J. Cohen

April 25, 2013

Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism

Presentation TCTAP 2013

Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism

Presenter: David J. Cohen

April 24, 2013

Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty

Presentation TCT 2013

Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty

Presenter: Annapoorna Kini, Roxana Mehran, Nilusha Gukathasan, Ziad Sergie, Mauricio Cohen, Jennifer Yu, Usman Baber, Samantha Sartori, Robert Pyo, Kleanthis Theodoropoulos, Roja Thapi, Elliot Elias, Socrates Kakoulides, Evan Jocobs, David knopf, Jason Kovacic, Raj Vadde, Brian O'Neill, Samin Sharma, George Dangas

January 31, 2013

Cost Effectiveness of the MitraClip® Compared with Mitral Valve Surgery: 12-month Results from the EVEREST II Randomized Controlled Trial

Presentation TCT 2013

Cost Effectiveness of the MitraClip® Compared with Mitral Valve Surgery: 12-month Results from the EVEREST II Randomized Controlled Trial

Presenter: Matthew Reynolds, Benjamin Galper, Patricia Apruzzese, Joshua Walczak, Laura Mauri, Ted Feldman, Donald Glower, David Cohen

January 31, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

December 02, 2012

News Daily News

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

December 02, 2012

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

November 12, 2012

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

November 12, 2012

A Stepwise Approach to Building a Career in Interventional Cardiology Research

Presentation TCT 2012

A Stepwise Approach to Building a Career in Interventional Cardiology Research

Presenter: David Cohen

October 25, 2012

Personalized Medicine: Current Tools and the Future of Clinical Research in Practice

Presentation TCT 2012

Personalized Medicine: Current Tools and the Future of Clinical Research in Practice

Presenter: David Cohen

October 22, 2012

News Conference News TCT 2012

PARTNER Analyses Provide Important Insights into TAVR

October 22, 2012

Lessons from the Quality-of-Life Studies in Inoperable and High-Risk Patients

Presentation TCT 2012

Lessons from the Quality-of-Life Studies in Inoperable and High-Risk Patients

Presenter: David Cohen

October 22, 2012

An Introduction to Cost-Effectiveness Analyses: Who Pays (and Should They)?

Presentation TCT 2012

An Introduction to Cost-Effectiveness Analyses: Who Pays (and Should They)?

Presenter: David Cohen

October 22, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.